Related Experiment Video
Updated: May 30, 2026
05:40
Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs
Published on: December 22, 2023
Uterine dehiscence in early second trimester.
Lisa C Zuckerwise1, Hakan Cakmak, Anna K Sfakianaki
1From the Yale University School of Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, New Haven, Connecticut.
Obstetrics and Gynecology
|July 20, 2011
Summary
Diagnosing uterine dehiscence in early pregnancy via ultrasound is uncommon. This case highlights the management challenges and uncertainties surrounding pregnancy outcomes with this rare condition.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Diagnostic Imaging
Background:
- Uterine dehiscence diagnosis in the early second trimester via ultrasonography is rare.
- The impact of antenatally diagnosed uterine dehiscence on pregnancy outcomes remains unclear.
- Increasing cesarean delivery rates may lead to more cases of uterine dehiscence.
Observation:
- An asymptomatic pregnant woman at 19 weeks gestation presented for an anatomy survey.
- Ultrasound revealed uterine dehiscence at the site of a previous hysterotomy.
- The patient was admitted for expectant management but opted for pregnancy termination at 22 weeks.
Findings:
- Pregnancy termination was successfully performed via classical hysterotomy without complications.
- The case illustrates a rare instance of early second-trimester uterine dehiscence.
- Ultrasound technology plays a crucial role in diagnosing uterine dehiscence antenatally.
Implications:
- Obstetricians must prepare for management dilemmas posed by antenatally diagnosed uterine dehiscence.
- The comparative risks of expectant management versus termination for uterine dehiscence are theoretical.
- Further research is needed on optimal timing of delivery and methods for termination in such cases.
Related Concept Videos
01:33Cleavage and Blastulation
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
01:18Uterus and Cervix
The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs of...
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs of...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
01:19Histology of the Uterus
The uterine wall consists of three histological layers: the perimetrium, myometrium, and endometrium. The outermost perimetrium is a thin, serous membrane connected with the broad ligament on the sides, which helps anchor the uterus in the pelvic cavity. The thickest layer, myometrium, is mainly made up of smooth muscle tissue bundles. Its contractions are vital in facilitating the expulsion of the uterine lining, fetus, and placenta during menstruation and childbirth.
The endometrium is the...
The endometrium is the...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:18Menses Phase
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...